Idiopathic interstitial pneumonias in 2015: A new era

Respirology

Volumn 20, Issue 5, 2015, Pages 697-698

  Corte, Tamera J ^a,b   Collard, Harold ^c   Wells, Athol U ^d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

biomarker; cryobiopsy; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; management

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; NINTEDANIB; PIRFENIDONE; PLACEBO; PREDNISONE;

CONNECTIVE TISSUE DISEASE; EDITORIAL; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SMOKING CESSATION; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS;

EID: 84931576979     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12559     Document Type: Editorial

References (11)

1. Wuyts WA, Antoniou KM, Borensztajn K, et-al. Combination therapy: the future of management for idiopathic pulmonary fibrosis? The Lancet Respiratory medicine 2014; 2: 933-942.
2. Idiopathic Pulmonary Fibrosis Clinical Research N, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G,. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2093-2101.
3. King TE Jr, Bradford WZ, Castro-Bernardini S, et-al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2083-2092.
4. Richeldi L, du Bois RM, Raghu G, et-al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2071-2082.
5. Travis WD, Costabel U, Hansell DM, et-al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733-748.
6. Fischer A, Brown KK,. Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res (Hoboken) 2015; 67: 4-11.
7. Casoni GL, Tomassetti S, Cavazza A, et-al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 2014; 9: e86716.
8. Konishi K, Gibson KF, Lindell KO, et-al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 180: 167-175.
9. Zhang Y, Kaminski N,. Biomarkers in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med. 2012; 18: 441-446.
10. Kropski JA, Pritchett JM, Zoz DF, et-al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am. J. Respir. Crit. Care Med. 2015; 191: 417-426.
11. Loomis-King H, Flaherty KR, Moore BB,. Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis. Curr. Opin. Pharmacol. 2013; 13: 377-385.